Rhumbline Advisers Sells 2,079 Shares of Aspen Aerogels, Inc. $ASPN

Rhumbline Advisers cut its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 2.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 90,965 shares of the construction company’s stock after selling 2,079 shares during the quarter. Rhumbline Advisers owned 0.11% of Aspen Aerogels worth $581,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. GAMMA Investing LLC grew its holdings in Aspen Aerogels by 1,998.7% during the 1st quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company’s stock worth $210,000 after acquiring an additional 3,158 shares during the last quarter. Acadian Asset Management LLC bought a new stake in Aspen Aerogels during the 1st quarter worth approximately $43,000. Banque Cantonale Vaudoise bought a new stake in Aspen Aerogels during the 1st quarter worth approximately $45,000. Exchange Traded Concepts LLC grew its holdings in Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company’s stock worth $48,000 after acquiring an additional 6,109 shares during the last quarter. Finally, CWM LLC grew its holdings in Aspen Aerogels by 2,137.9% during the 1st quarter. CWM LLC now owns 8,325 shares of the construction company’s stock worth $53,000 after acquiring an additional 7,953 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ASPN shares. Canaccord Genuity Group reduced their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Barclays lowered shares of Aspen Aerogels from an “equal weight” rating to an “underweight” rating and boosted their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.50.

Insider Activity at Aspen Aerogels

In other news, CAO Santhosh P. Daniel sold 4,410 shares of the company’s stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the sale, the chief accounting officer directly owned 19,879 shares of the company’s stock, valued at approximately $145,315.49. This represents a 18.16% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 3.40% of the company’s stock.

Aspen Aerogels Trading Up 6.5%

NYSE:ASPN opened at $7.29 on Tuesday. The firm’s fifty day moving average is $7.13 and its 200-day moving average is $6.44. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $30.24. The firm has a market cap of $599.99 million, a P/E ratio of -1.91 and a beta of 2.65.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. During the same period in the prior year, the firm posted $0.21 EPS. The company’s quarterly revenue was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. Equities analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.